Ron H.N. van Schaik
Dept Clinical Chemistry, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Prof Dr Ron van Schaik (PhD/FACB/EuSpLM) is Director of the International (IFCC) Pharmacogenetics Expertcenter and leads the Unit Research & Development of the Dept. Clinical Chemistry, Erasmus University Medical Center Rotterdam, The Netherlands. His focus is clinical implementation of Pharmacogenetics. Research topics include Transplantation, Oncology, Pain and Psychiatry, as well as cell free DNA applications in oncology and solid organ transplantation. He has published >260 articles in the field of pharmacogenetics and is also involved in prostate cancer research and cardiac markers. Prof van Schaik has given >400 invited lectures at national and international conferences, and participates in several international committees on pharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair, 2008–2016), IATDMCT PGx-Committee (chair, 2008-2014), IUPHAR PGx-committee (2015-present), European Society for Pharmacogenomics and Personalised Therapy (President, 2016-present), AACC Personalized Medicine Division (2012-2016) and PGx Working Group EMA (2010-present) and the Dutch PGx-working group (DPWG; 2005-present). He received the Ortho Clinical Diagnostics Award for outstanding research (2001), the AACC Outstanding Speaker Award (2009) and the AACC/Mol Pathology Award for Outstanding Scientific Research (2010).
Member: ESPT, AACC, IATDMCT, CPIC, KNMP, NVKC, IUPHAR, NVKFB, Golden Helix, G2M, Global Medicine Alliance, DPWG, KNMP, EMA